FDA Drug Recalls

832 recalls, newest first

Jan 15, 2020 Class II · Moderate risk

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0623-1 D-0968-2020

Jan 15, 2020 Class II · Moderate risk

Methylcobalamin Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0331-3 D-0967-2020

Jan 15, 2020 Class II · Moderate risk

Methylcobalamin Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0338-3 D-0966-2020

Jan 15, 2020 Class II · Moderate risk

Methionine/Inositol/Choline Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0215-3 D-0965-2020

Jan 15, 2020 Class III · Low risk

Magnesium Chloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0225-5 D-0964-2020

Jan 15, 2020 Class II · Moderate risk

Lysine Hydrochloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0342-3 D-0963-2020

Jan 15, 2020 Class II · Moderate risk

Lidocaine HCL

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-1011-5 D-0962-2020

Jan 15, 2020 Class II · Moderate risk

Levocarnitine Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-9260-3 D-0961-2020

Jan 15, 2020 Class II · Moderate risk

Polyoxyl Lauryl Ether

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-060-3 D-0960-2020

Jan 15, 2020 Class II · Moderate risk

Arginine Hydrochloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0341-3 D-0959-2020

Jan 15, 2020 Class II · Moderate risk

Hydroxyprogesterone Caproate Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0532-5 D-0958-2020

Jan 15, 2020 Class II · Moderate risk

Hydroxocobalamin Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0339-3 D-0957-2020

Jan 15, 2020 Class II · Moderate risk

Human Chorionic Gonadotropin

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0533-1 D-0956-2020

Jan 15, 2020 Class II · Moderate risk

Glycine Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0344-3 D-0955-2020

Jan 15, 2020 Class II · Moderate risk

Glycerin

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0464-1 D-0954-2020

Jan 15, 2020 Class II · Moderate risk

Glutathione Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-1231-3 D-0953-2020

Jan 15, 2020 Class II · Moderate risk

Dexpanthenol Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0214-3 D-0952-2020

Jan 15, 2020 Class II · Moderate risk

Dexamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0630-1 D-0951-2020

Jan 15, 2020 Class II · Moderate risk

Deoxycholic Acid Sodium Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0462-3 D-0950-2020

Jan 15, 2020 Class II · Moderate risk

Cyanocobalamin/Folinic Acid Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0333-3 D-0949-2020

Jan 15, 2020 Class II · Moderate risk

Cyanocobalamin Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0330-3 D-0948-2020

Jan 15, 2020 Class II · Moderate risk

Coenzyme Q10 Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0411-1 D-0947-2020

Jan 15, 2020 Class II · Moderate risk

Calcium Chloride Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0225-3 D-0946-2020

Jan 15, 2020 Class II · Moderate risk

Biotin (Vitamin H)

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0220-3 D-0945-2020

Jan 15, 2020 Class II · Moderate risk

Betamethasone Acetate/Betamethasone

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0621-5 D-0944-2020

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061